Market Price

84.72 

0.60 0.7%

as of May 29 '20

52 Week Range:

43.01 90.94


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Sensé¬óbeautiful science products, such as personal care products that support healthy skin and hair through topical nourishment, moisturization, and protection; Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '11 Dec '12 Dec '13 Dec '14 Jan '15 Oct '15 Jan '16 Oct '16 Dec '17 Dec '18 Dec '19
Equity (BVPS) 5.33
6.71
8.59
8.10
12.27
12.57
15.10
18.48
14.51
growth rate 25.9% 28.0% -5.7% 23.1% 1.2% 20.1% 22.4% -21.5%
Earnings BIT 77.48
98.43
116.58
116.10
141.66
138.62
132.50
188.35
146.19
growth rate 27.0% 18.4% -0.2% 10.5% -2.2% -4.4% 42.2% -22.4%
Avg.PE 9.32
7.40
13.59
19.89
19.89
14.44
21.33
21.00
17.08
growth rate -20.6% 83.7% 46.4% 0.0% -10.1% 47.7% -1.6% -18.7%
ROA 22.64
25.96
24.86
21.32
24.47
22.38
12.63
23.51
18.77
growth rate 14.7% -4.2% -14.2% 7.1% -4.4% -43.6% 86.1% -20.2%
ROE 31.81
36.96
35.43
31.24
37.05
33.01
18.17
33.47
27.06
growth rate 16.2% -4.1% -11.8% 8.9% -5.6% -45.0% 84.2% -19.2%
ROIC 31.74
36.88
35.29
31.14
36.77
32.76
17.79
32.70
25.66
growth rate 16.2% -4.3% -11.8% 8.7% -5.6% -45.7% 83.8% -21.5%
Cur. Ratio 1.78
1.87
2.39
1.76
1.86
2.01
2.41
2.64
2.42
growth rate 5.1% 27.8% -26.4% 2.8% 4.0% 19.9% 9.5% -8.3%
Quick Ratio 0.94
1.12
1.66
1.14
1.18
1.39
1.85
1.96
1.79
growth rate 19.2% 48.2% -31.3% 1.7% 8.5% 33.1% 6.0% -8.7%
Leverage 1.41
1.44
1.41
1.52
1.50
1.45
1.43
1.42
1.47
growth rate 2.1% -2.1% 7.8% -0.7% -1.7% -1.4% -0.7% 3.5%
Balance Sheet Dec '11 Dec '12 Dec '13 Dec '14 Jan '15 Oct '15 Jan '16 Oct '16 Dec '17 Dec '18 Dec '19
Acct.Receivable 0.00
0.00
11.03
11.78
17.04
13.46
14.03
8.76
growth rate 3.4% 44.6% -21.1% 4.3% -37.6%
Acct.Payable 7.95
7.04
9.50
7.78
10.04
9.04
11.79
9.95
12.53
growth rate -11.5% 35.0% -9.5% 13.6% -10.0% 30.4% -15.6% 25.9%
Cur.Assets 106.06
132.55
229.05
190.93
244.26
277.86
340.16
392.34
329.28
growth rate 25.0% 72.8% -8.7% 13.1% 13.8% 22.4% 15.3% -16.1%
Total Assets 244.50
267.36
368.47
350.58
423.24
470.64
519.27
554.46
516.93
growth rate 9.4% 37.8% -2.5% 9.9% 11.2% 10.3% 6.8% -6.8%
Cash 50.35
70.84
137.34
111.13
143.21
175.77
247.13
214.33
234.83
growth rate 40.7% 93.9% -10.1% 13.5% 22.7% 40.6% -13.3% 9.6%
Inventory 36.97
36.48
47.24
45.25
66.12
64.81
62.92
81.95
68.91
growth rate -1.3% 29.5% -2.1% 20.9% -2.0% -2.9% 30.3% -15.9%
Cur.Liabilities 59.70
70.84
95.87
108.71
131.41
138.49
141.18
148.69
136.10
growth rate 18.7% 35.3% 6.5% 10.0% 5.4% 1.9% 5.3% -8.5%
Liabilities 70.59
81.78
107.95
120.42
142.39
145.36
156.06
163.32
165.22
growth rate 15.9% 32.0% 5.6% 8.7% 2.1% 7.4% 4.7% 1.2%
LT Debt 0.00 0.00 0.00
growth rate
Equity 173.91
185.57
260.52
230.16
280.85
325.29
363.21
391.15
351.71
growth rate 6.7% 40.4% -6.0% 10.5% 15.8% 11.7% 7.7% -10.1%
Common Shares 31.00
30.00
28.00
27.00
26.00
25.00
25.00
25.00
23.00
growth rate -3.2% -6.7% -3.6% -1.9% -1.9% 0.0% 0.0% -8.0%
Cash Flow Statement Dec '11 Dec '12 Dec '13 Dec '14 Jan '15 Oct '15 Jan '16 Oct '16 Dec '17 Dec '18 Dec '19
Capital Expenditures 10.64
8.43
8.05
20.42
23.73
32.70
13.22
11.43
16.57
growth rate -20.8% -4.5% 59.3% 7.8% 37.8% -59.6% -13.5% 44.9%
Cash Dividends 0.00 0.00
growth rate
Cash From OA 70.11
92.81
98.89
105.19
111.47
136.89
123.77
152.12
126.73
growth rate 32.4% 6.6% 3.1% 2.9% 22.8% -9.6% 22.9% -16.7%
FCF per Share 2.02
2.83
3.02
3.08
3.38
3.37
4.34
6.26
4.15
growth rate 40.1% 6.7% 2.0% 4.8% -0.2% 28.8% 44.2% -33.7%
Sale Purchase of Stock -33.42
-67.99
-17.63
10.97
-61.18
-64.61
-50.00
growth rate 0.0% 0.0% 100.0% -100.0% 0.0% 0.0%
FCF 59.00
84.00
91.00
85.00
84.76
88.00
87.74
104.00
111.00
141.00
110.00
growth rate 42.4% 8.3% -6.6% -0.3% 3.8% -0.3% 18.5% 6.7% 27.0% -22.0%
Income Statement Dec '11 Dec '12 Dec '13 Dec '14 Jan '15 Oct '15 Jan '16 Oct '16 Dec '17 Dec '18 Dec '19
Sales 581.94
648.73
718.18
790.47
918.50
1,006.08
1,047.27
1,189.25
1,060.90
growth rate 11.5% 10.7% 4.9% 7.8% 9.5% 4.1% 13.6% -10.8%
Op.Income 50.75
66.43
79.02
116.10
141.66
138.62
132.50
188.35
146.19
growth rate 30.9% 19.0% 21.2% 10.5% -2.2% -4.4% 42.2% -22.4%
IBT 77.48
98.43
116.58
115.65
142.59
138.55
134.64
191.51
150.50
growth rate 27.0% 18.5% -0.4% 11.0% -2.8% -2.8% 42.2% -21.4%
Net Income 50.75
66.43
79.02
76.64
94.67
100.04
62.54
126.22
100.53
growth rate 30.9% 19.0% -1.5% 11.2% 5.7% -37.5% 101.9% -20.4%
EPS 1.63
2.23
2.78
2.80
3.59
3.99
2.53
5.12
4.41
growth rate 36.8% 24.7% 0.7% 13.2% 5.4% -36.6% 102.4% -13.9%
Gross Profit 480.25
532.92
590.74
649.68
758.82
825.89
867.86
988.54
873.40
growth rate 11.0% 10.9% 4.9% 8.1% 8.8% 5.1% 13.9% -11.7%

Quarterly Statements

Item Name Mar '19 Jun '19 Sep '19 Dec '19 Mar '20
Earnings BIT 35.00
31.16
35.46
44.57
39.01
growth rate -11.0% 13.8% 25.7% -12.5%
Balance Sheet Mar '19 Jun '19 Sep '19 Dec '19 Mar '20
Acct.Receivable 8.76
growth rate
Acct.Payable 11.70
11.69
8.61
12.53
11.82
growth rate -0.1% -26.4% 45.6% -5.6%
Cur.Assets 370.18
348.78
282.98
329.28
286.76
growth rate -5.8% -18.9% 16.4% -12.9%
Total Assets 551.58
532.40
463.04
516.93
473.75
growth rate -3.5% -13.0% 11.6% -8.4%
Cash 225.04
231.35
182.75
234.83
194.10
growth rate 2.8% -21.0% 28.5% -17.4%
Inventory 86.47
88.13
76.14
68.91
60.57
growth rate 1.9% -13.6% -9.5% -12.1%
Cur.Liabilities 129.99
128.76
129.65
136.10
124.50
growth rate -1.0% 0.7% 5.0% -8.5%
Liabilities 160.37
148.25
148.76
165.22
156.14
growth rate -7.6% 0.3% 11.1% -5.5%
LT Debt 11.81
growth rate
Equity 391.22
384.16
314.29
351.71
317.61
growth rate -1.8% -18.2% 11.9% -9.7%
Common Shares 0.02
0.02
0.02
0.02
0.02
growth rate 0.0% -4.4% 0.0% -4.6%
Cash Flow Statement Mar '19 Jun '19 Sep '19 Dec '19 Mar '20
Capital Expenditures 2.58
4.55
4.24
5.20
7.27
growth rate 76.7% -6.8% 22.5% 39.8%
Cash Dividends
growth rate
Cash From OA 5.52
15.16
50.31
55.74
30.79
growth rate 174.6% 231.9% 10.8% -44.8%
Sale Purchase of Stock
growth rate
FCF 2.94
10.61
46.07
50.54
23.52
growth rate 260.2% 334.4% 9.7% -53.5%
Income Statement Mar '19 Jun '19 Sep '19 Dec '19 Mar '20
Sales 272.99
256.02
260.60
271.30
266.62
growth rate -6.2% 1.8% 4.1% -1.7%
Op.Income 35.00
31.16
35.46
44.57
39.01
growth rate -11.0% 13.8% 25.7% -12.5%
IBT 36.29
32.51
35.89
45.80
39.16
growth rate -10.4% 10.4% 27.6% -14.5%
Net Income 24.17
21.38
24.22
30.75
26.55
growth rate -11.6% 13.3% 27.0% -13.7%
EPS
growth rate
Gross Profit 227.09
209.52
212.78
224.01
220.56
growth rate -7.7% 1.6% 5.3% -1.5%
R&D
growth rate

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (29.00)

YOY Growth Grade:

D (43.92)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 17.08 19.51 16.98
EPS / Growth 12.0% 4.34 10.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 6.7%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 6.7% 9.6% 9.6%
Future PE 13.40 17.73 17.73
Future EPS 8.31 10.83 10.83
Value Price
MOS %
27.51
-67.5%
47.48
-44.0%
47.48
-44.0%
MOS Price 13.76 23.74 23.74
IRT 12.32 10.88 10.88

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.